Enbiosis Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 5

Enbiosis General Information

Description

Developer of an artificial intelligence algorithm analyzing biotechnology intended to improve the quality of human health. The company's technology specializes in combining artificial intelligence and microbiome science to analyze the human gut microbiome to provide personalized health guidance, which covers a diet program and prebiotics, enabling people to reach deep into their inner world with the microbiome and stay healthy with diet.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 25 Cabot Square
  • London E14 4QZ
  • England, United Kingdom
Primary Industry
Other Healthcare Technology Systems
Corporate Office
  • 25 Cabot Square
  • London E14 4QZ
  • England, United Kingdom

Enbiosis Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enbiosis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 22-Jan-2024 $1.5M Completed Generating Revenue
3. Accelerator/Incubator 01-May-2023 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Early Stage VC 04-Jan-2021 Completed Generating Revenue
To view Enbiosis’s complete valuation and funding history, request access »

Enbiosis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Class B
Class A
Class B
Class A
Class B 4,766 $0.001000 $18.17 $18.17 1x $18.17 10.43%
Class B 21,200 $0.001000 $17.62 $17.62 1x $17.62 46.39%
To view Enbiosis’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Enbiosis Patents

Enbiosis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4309662-A1 Microorganisms converting inositol to butyrate Inactive 19-Jul-2022
US-20240026310-A1 Microorganisms converting inositol to butyrate Inactive 19-Jul-2022
EP-4309663-A1 Microorganisms synthesizing anti-inflammatory molecules Inactive 19-Jul-2022
US-20240024376-A1 Microorganisms synthesizing anti-inflammatory molecules Pending 19-Jul-2022 A61K35/74

Enbiosis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enbiosis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
QInvest Portfoy Yonetimi Asset Manager Minority
Tech Ventures Venture Capital Minority
Grow London Accelerator/Incubator
Pragma Capital Partners PE/Buyout Minority
Yapay Zeka Fabrikasi Corporate Venture Capital Minority
To view Enbiosis’s complete investors history, request access »

Enbiosis FAQs

  • When was Enbiosis founded?

    Enbiosis was founded in 2019.

  • Where is Enbiosis headquartered?

    Enbiosis is headquartered in London, United Kingdom.

  • What is the size of Enbiosis?

    Enbiosis has 22 total employees.

  • What industry is Enbiosis in?

    Enbiosis’s primary industry is Other Healthcare Technology Systems.

  • Is Enbiosis a private or public company?

    Enbiosis is a Private company.

  • What is the current valuation of Enbiosis?

    The current valuation of Enbiosis is .

  • What is Enbiosis’s current revenue?

    The current revenue for Enbiosis is .

  • How much funding has Enbiosis raised over time?

    Enbiosis has raised $1.5M.

  • Who are Enbiosis’s investors?

    QInvest Portfoy Yonetimi, Tech Ventures, Grow London, Pragma Capital Partners, and Yapay Zeka Fabrikasi have invested in Enbiosis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process